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Abstract
 
Although hematopoietic stem cell (HSC) migration into and out of sites of active hematopoie-
sis is poorly understood, it is a critical process that underlies modern clinical stem cell transplan-
tation and may be important for normal hematopoietic homeostasis. Given the established roles
of chemotactic cytokine (chemokine)-directed migration of other leukocyte subsets, the migra-
tion of murine HSC to a large panel of CC and CXC chemokines was investigated. HSC mi-
grated only in response to stromal derived factor-1
 
 
 
, the ligand for the CXC chemokine re-
ceptor 4 (CXCR4). CXCR4 expression by HSC was confirmed by reverse transcription
polymerase chain reaction analysis. Surprisingly, HSC also expressed mRNA for CCR3 and
CCR9, although they failed to migrate to the ligands for these receptors. The sharply restricted
chemotactic responsiveness of HSC is unique among leukocytes and may be necessary for the
specific homing of circulating HSC to bone marrow, as well as for the maintenance of HSC in
hematopoietic microenvironments.
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Introduction
 
Hematopoietic stem cells (HSC)
 
*
 
 are rare, pluripotent, self-
renewing cells that give rise to all hematopoietic lineages
(1) and migrate among various hematopoietic tissues. The
site of hematopoiesis changes several times during embry-
onic and fetal development in a process thought to be de-
pendent on HSC migration (for review see reference 2). In
normal adult animals, HSC continuously migrate from the
bone marrow (BM) to the blood and back to the BM, in
such a way that circulating HSC are always available in pe-
ripheral blood to fill open BM HSC niches (3–5). Large-
scale HSC mobilization from BM to blood is induced in
adult animals by treatment with cytokines (e.g., G-CSF)
and/or cytotoxic drugs (e.g., cyclophosphamide [Cy]) (1).
Drug-induced HSC mobilization from BM to blood and
the rehoming of transplanted HSC from blood to BM are
critical for modern therapeutic transplants that include stem
cells. Finally, HSC have recently been shown to be capable
of giving rise to hepatocytes (6), and BM cells enriched for
HSC have been shown to be capable of giving rise to epi-
thelial cells (7) and cardiac muscle cells (8). It has been pro-
posed that HSC migration into sites of injury may be a
mechanism by which damaged tissues are repaired (6).
These new discoveries lend urgency to efforts to under-
stand the mechanisms of HSC migration.
 
Adhesion molecules, such as 
 
 
 
4
 
 
 
1 integrin, have been
implicated in both HSC mobilization as well as in the re-
homing of transplanted HSC placed in the circulation (9,
10). Roles for chemotactic cytokines (chemokines) in he-
matopoietic stem and progenitor cell biology have also
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Abbreviations used in this paper: 
 
APC, allophycocyanin; BLC, B lym-
phocyte chemokine; BM, bone marrow; chemokine, chemotactic cyto-
kine; Cy, cyclophosphamide; HSC, hematopoietic stem cell(s); LT-HSC,
long-term repopulating hematopoietic stem cell(s); MPB, mobilized pe-
ripheral blood; MIG, monokine induced by IFN-
 
 
 
; MIP, macrophage
inflammatory protein; RANTES, regulated upon activation, normal T
expressed and secreted; RT, reverse transcriptase; SDF-1
 
 
 
, stromal cell–
derived factor-1
 
 
 
; SM, staining medium; ST-HSC, short-term repopu-
lating hematopoietic stem cell(s); TECK, thymus-expressed chemokine;
WBM, whole bone marrow. 
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been proposed. HSC are rapidly mobilized from BM to
blood after the administration of the chemokine IL-8 to
mice (11) or to monkeys (12), and serum IL-8 levels spike
just before mobilization after the induction with G-CSF
(13). However, the effect of IL-8 in inducing HSC mobi-
lization appears to be indirect (14, 15). The possibility of a
direct role for the chemokine stromal cell–derived factor-
1
 
  
 
(SDF-1
 
 
 
) in progenitor mobilization was raised by a
study of human BM and mobilized peripheral blood
(MPB) CD34
 
 
 
 cells, in which MPB CD34
 
 
 
 cells did not
respond as well to SDF-1
 
 
 
 as to CD34
 
 
 
 cells isolated from
BM (16). The authors proposed that the alteration in
SDF-1
 
 
 
 responsiveness might be part of the mechanism of
progenitor mobilization, although only a fraction of hu-
man CD34
 
 
 
 cells are HSC (17, 18). Finally, SDF-1
 
 
 
 has
been implicated in the strikingly specific homing of trans-
planted hematopoietic progenitors to BM. SDF-1
 
 
 
 is con-
stitutively expressed on human BM endothelium and ap-
pears to cooperate with 
 
 
 
4
 
 
 
1 integrin (very late antigen-4)
and 
 
 
 
L
 
 
 
2 integrin (LFA-1) in inducing the arrest of circu-
lating progenitors on vascular endothelium (19, 20). As of
this writing, however, large panel studies on the ability of
chemokines to induce chemotaxis of normal and mobi-
lized HSC have not been published. Therefore, we sought
to examine chemotaxis of HSC in a mouse model using a
panel of chemokines that bind most known chemokine
receptors.
We have previously shown that virtually all of the re-
constituting activity of HSC isolated from the BM of un-
treated C57BL/Ka-Thy-1.1 mice and of mobilized HSC
isolated from Cy/G-CSF–treated C57BL/Ka-Thy-1.1
mice is contained in two phenotypically defined popula-
tions: Thy-1.1
 
lo
 
Sca-1
 
 
 
Lin
 
 
 
c-Kit
 
 
 
Mac-1
 
  
 
cells that are
mostly long-term repopulating HSC (LT-HSC), and
Thy-1.1
 
lo
 
Sca-1
 
 
 
Lin
 
 
 
c-Kit
 
 
 
Mac-1
 
lo
 
 cells that are mostly
short-term repopulating HSC (ST-HSC) (21–23). Here,
the in vitro chemotaxis of LT-HSC and ST-HSC, ob-
tained from the BM of untreated mice, in response to a
panel of chemokines binding most currently described
chemokine receptors from the CC and CXC families, was
investigated. Chemotaxis of HSC obtained from mice
treated with a mobilizing regimen of Cy/G-CSF in re-
sponse to SDF-1
 
 
 
 was also studied. In parallel, the ex-
pression of mRNA of chemokine receptors on both LT-
HSC and ST-HSC derived from the BM of untreated
mice was examined. These studies provide a large-scale
survey of HSC chemotactic responses and provide evi-
dence that mouse HSC possess mRNA for several che-
mokine receptors, yet only migrate in vitro in response to
one chemokine, SDF-1
 
 
 
.
 
Materials and Methods
 
Mice
 
6–12-wk-old C57BL/Ka-Thy-1.1 mice were bred and main-
tained at the Stanford University Laboratory Animal Facility, and
given acidified water (pH 2.5) and rodent chow ad libitum.
 
HSC Mobilization
 
Cy and G-CSF were administered as previously described (23).
HSC were analyzed on day 4 of the regimen, due to the expan-
sion of HSC in the BM and the large numbers of HSC in the
blood and spleen on that day (23).
 
Tissue Processing
 
Single cell suspensions of BM and spleen cells were prepared
as previously described (23). Blood was collected from animals
after heparin injection and induction of anesthesia with methoxy-
flurane (Mallinckrodt Veterinary, Inc.). After the incision of
the right atrium, blood was removed from the thoracic cavity
with a Pasteur pipette. The left ventricle was then perfused via a
25-gauge needle with 10 mM EDTA in HBSS (GIBCO BRL)
and blood/EDTA from the thoracic cavity was removed. Blood
was subjected to dextran sedimentation and ammonium chloride
erythrocyte lysis as previously described (23). Splenic erythro-
cytes were lysed in all experiments and BM erythrocytes were
lysed in most experiments.
 
Antibodies
 
mAbs used in immunofluorescence staining were prepared
from hybridomas and included 19XE5 (anti–Thy-1.1), 2B8
(anti–c-Kit), and E13 (anti–Sca-1, Ly6A/E). Lineage marker
mAbs included KT31.1 (rat anti–mouse CD3), GK1.5 (rat anti–
mouse CD4), 53-7.3 (rat anti–mouse CD5), 53-6.7 (rat anti–
mouse CD8), Ter119 (rat anti–mouse erythrocyte-specific
antigen), 6B2 (rat anti–mouse B220), 8C5 (rat anti–mouse Gr-1),
and M1/70 (rat anti–mouse Mac-1). Fc receptors were blocked
with mAb 2.4G2 (anti-FcR) at appropriate points in staining
procedures.
 
Depletion of Lineage
 
 
 
 Cells for Chemotaxis Assays
 
Cells were stained in HBSS/2% calf serum with the lineage
marker antibodies listed above at 10
 
8
 
 cells/ml of previously deter-
mined optimal concentrations of antibody solution on ice for 25
min, rinsed twice in staining medium (SM), and enriched by in-
cubation on a rocking platform at 4
 
 
 
C for 20 min with SM-
washed sheep anti–rat IgG magnetic beads (Dynabeads; Dynal) at
a 1:1 ratio of beads/cells in SM. After the removal of beads and
attached cells, the remaining cells were incubated on a rocking
platform at 4
 
 
 
C for 30 min with fresh washed beads at a 4:1 ratio
of beads/cells, and a second round of bead/cell removal was ac-
complished. Typical lineage staining profiles of whole BM and
lineage-depleted BM are shown in Fig. 1 A.
 
Chemotaxis Assay
 
Lineage-depleted tissues were suspended in RPMI medium
(GIBCO BRL) with 10% serum and incubated in polystyrene tis-
sue culture flasks at 37
 
 
 
C for 1 h to remove adherent cells and al-
low time for resensitization of potentially desensitized chemokine
responses (24). Cells were then placed into a transwell chemotaxis
assay as previously described (25) at 5 
 
 
 
 10
 
5 
 
  
 
2 
 
 
 
 10
 
6
 
 cells per
top well. The following chemokines were added to the bottom
well, and cells were allowed to migrate for 2 h at 37
 
 
 
C: mouse
JE, mouse eotaxin, human thymus- and activation-regulated
chemokine, mouse regulated upon activation, normal T ex-
pressed and secreted (RANTES), mouse macrophage inflamma-
tory protein (MIP)-1
 
 
 
, human MIP-3
 
 
 
, human I-309, mouse
KC, and human SDF-1
 
 
 
 (PeproTech); mouse MIP-1
 
 
 
, human
MIP-3
 
 
 
, mouse thymus–expressed chemokine (TECK), mouse
monokine induced by IFN-
 
 
 
 (MIG), and mouse B lymphocyte 
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chemokine (BLC)/BCA-1 (R&D Systems); and human IL-8 (a
gift from K. Matsushima, University of Tokyo, School of Medi-
cine, Tokyo, Japan). Optimal chemokine concentrations were
determined in preliminary chemotaxis assays using BM cells or
splenocytes. Two chemokines (I-309 and eotaxin) did not elicit
responses from any BM or splenic subset, and therefore were
used at published concentrations (24). Biological activity of I-309
and eotaxin was confirmed using cell lines expressing CCR8 and
CCR3, respectively. Chemokines were used at final concentra-
tions of 100 nM, with the following exceptions: 1 nM JE; 3 nM
MIP-1
 
 
 
; 5 nM G-CSF; 50 nM SDF-1
 
 
 
; 300 nM KC and
TECK; and 500 nM BLC.
 
Enumeration of Migrated HSC
 
After the addition of a fixed number of 15 
 
 
 
m polystyrene
beads (Polysciences) for normalization of cell numbers among
wells as previously described (25), migrated cells were carefully
collected from bottom wells, centrifuged, restained with lineage
marker antibodies, and then stained with PE-conjugated goat
anti–rat polyclonal antibody (Jackson ImmunoResearch Labora-
tories) to visualize lineage markers. Cells were then washed twice
and stained with a cocktail containing FITC-conjugated (Molec-
ular Probes) anti–Thy-1.1 (19XE5), allophycocyanin-conjugated
(APC; Cyanotech) anti–c-Kit (2B8), and TxR-conjugated (Mo-
lecular Probes) anti–Sca-1 (E13). In some experiments, PE-con-
jugated lineage antibodies were also included with the anti–Thy-
1.1, anti–c-Kit, and anti–Sca-1 antibodies. Stained cells were
resuspended in SM containing propidium iodide in preparation
for flow cytometry.
 
Flow Cytometry
 
Cells were analyzed and sorted by multiparameter flow cytom-
etry on either a modified 2-laser FACS Vantage
 
®
 
 (Becton Dick-
inson), or a modified 3-laser cytometer (Cytomation, Inc. and
Becton Dickinson), made available through the flow cytometry
shared user group at Stanford University. Flow cytometry data
were analyzed using FloJo
 
®
 
 software (Treestar, Inc.). Representa-
tive gating for LT-HSC and ST-HSC is shown in Fig. 1 A.
 
Isolation of HSC for Reverse Transcription (RT)-PCR
 
HSC were enriched by positive selection for the c-Kit antigen
with magnetic beads (Miltenyi Biotec) as previously described
(26), and stained for flow cytometry with PE-conjugated lineage
mAbs as previously described, FITC-conjugated mAb against
Thy1.1, TxR-conjugated mAb against Sca-1, and APC-conju-
gated mAb against c-Kit. Lin
 
 
 
/lo
 
Thy-1.1
 
lo
 
Sca-1
 
 
 
c-Kit
 
  
 
HSC
were double sorted for RT-PCR analysis.
 
RT-PCR
 
RNA Isolation.
 
RNA from FACS
 
®
 
-sorted HSC (
 
 
 
20,000
cells) was extracted with Trizol (GIBCO BRL) according to the
manufacturer’s instructions. Isolated RNA was resuspended in di-
ethylpyrocarbonate (DEPC)-treated dH
 
2
 
O and incubated with
DNaseI (RNase-free; Boehringer) for 20 min at 37
 
 
 
C to remove
contaminating genomic DNA. Before RT, DNaseI was inacti-
vated and RNA was denatured by incubation at 70
 
 
 
C for 10 min.
 
RT.
 
After chilling on ice, RNA samples were split equally
into two 0.5-ml Eppendorf tubes (3.5 
 
 
 
l per tube), and used for
either the RT reaction (
 
 
 
RT), or for a control reaction in which
the RT was omitted (
 
 
 
RT control). 16.5 
 
 
 
l of the appropriate
(
 
 
 
 or 
 
 
 
RT) RT master mix was added to each tube containing
3.5 
 
 
 
l RNA, for a final volume of 20 
 
 
 
l.
 
RT Reaction Per Tube.
 
4 
 
 
 
l 5 
 
  
 
RT buffer; 2 
 
 
 
l 0.1 M
dithiolthreitol; 1 
 
 
 
l random hexamer (137 pmoles/
 
 
 
l); 8 
 
 
 
l
dNTPs (2.5 mM each dNTP); 0.5 
 
 
 
l RNAsin (Promega); plus
either 1 
 
 
 
l Superscript II RT (
 
 
 
RT; GIBCO BRL) or 1 
 
 
 
l
DEPC-dH
 
2
 
O (
 
 
 
RT control). RT reactions were performed by
incubation at 42
 
 
 
C for 1 h.
 
PCR.
 
Specific cDNA were amplified from the RT reactions
by hot-start PCR using 2 
 
 
 
l per tube of RT reaction as template
and a total volume of 50 
 
 
 
l per reaction. PCR master mix per
tube: 5 
 
 
 
l 10
 
 
 
 PCR buffer; 5 
 
 
 
l 25 mM MgCl
 
2
 
; 4 
 
 
 
l dNTPs
(2.5 mM each); 1.5 
 
 l primer 1 (16.7  M stock concentration);
1.5  l primer 2 (16.7  M stock concentration); 0.25  l Taq
polymerase; 30.75  l dH2O; and 2  l template (RT reaction).
PCR parameters were optimized for each primer set. PCR am-
plification was performed for 40 cycles. B. Fife (Northwestern
University, Chicago, IL) provided some of the chemokine recep-
tor PCR primer sequences.
PCR Primer Sequences. Oligonucleotide sequences specific
for chemokine receptors are listed in Table I.
Statistics
The RxC test of independence (using the G test) with the
Williams’ correction was used to analyze the data in Table III.
The Student’s t test was used to analyze data in Figs. 1 and 4 A. P
value of 0.05 was chosen as the limit of statistical significance.
Results
LT-HSC and ST-HSC Migrate Exclusively to SDF-1 .
We assayed the migration of LT-HSC and ST-HSC to a
panel of chemokines that bind the receptors listed in Table
II. In addition, G-CSF, a nonchemokine cytokine widely
used for HSC mobilization in experimental animals and in
humans, was tested. BM enriched for HSC was placed in
the top well of a transwell chamber, and chemokine-con-
taining medium was placed in the bottom well. Responding
cells were collected from the bottom well and stained with
antibodies to identify and enumerate HSC by flow cytome-
try (Fig. 1 A). Migration data were expressed as the percent-
age of input HSC contained in the population placed in the
top well that migrated to the bottom well. Strikingly, both
LT-HSC (Fig. 1 B) and ST-HSC (Fig. 1 C) migrated only
in response to SDF-1 , and did not respond significantly to
any of the other chemokines or to G-CSF. Although the
magnitude of SDF-1 –induced migration varied among
experiments (5.8–49% for LT-HSC and 7.3–57% for ST-
HSC), there was no significant difference in the degree of
migration to SDF-1  of LT-HSC and ST-HSC. Further-
more, the pattern of nonresponsiveness to other chemo-
kines did not vary between LT-HSC and ST-HSC.
SDF-1  Induces HSC Chemotaxis That Does Not Require
Non-HSC BM Cells. To further characterize SDF-1 –
induced HSC migration, we tested the requirement for an
SDF-1  gradient to induce HSC migration, or for non-
HSC BM cells to stimulate HSC migration to SDF-1  in
vitro. HSC migration to SDF-1  was chemotactic (polar-
ized migration toward a chemokine source) not chemoki-
netic (randomly induced migration), because HSC migra-
tion only occurred in a gradient of SDF-1  (bottom well1148 Hematopoietic Stem Cells Selectively Migrate to SDF-1 
only) and not when SDF-1  was presented in a uniform
manner (top and bottom wells) (Fig. 2 A). In addition,
HSC chemotaxis did not require the presence of non-
HSC BM cells. When HSC alone were sorted directly
into the top well of the transwell chamber, these individ-
ual sorted HSC migrated in response to SDF-1 , with a
migration index in the same range as that determined us-
ing a heterogeneous mixture of lineage-depleted BM cells
(Fig. 2 B).
Exposure to SDF-1  Does Not Alter the In Vivo Engraft-
ment Potential of HSC. We addressed the possibility that
the functional reconstituting ability of phenotypically iden-
tified migrated HSC was altered by exposure to SDF-1 
over the time course of our assay. We tested whether ex
vivo incubation or exposure to SDF-1  altered the engraft-
ment potential at near limit dilution doses of LT-HSC. As
shown in Table III, neither ex vivo incubation nor expo-
sure to SDF-1  significantly altered the engraftment poten-
tial of LT-HSC. 31 wk after the injection of 40 LT-HSC
that had been incubated alone for 1 h, followed by incuba-
tion with SDF-1  for 2 h, all recipient mice were engrafted
by donor cells and four out of eight mice displayed long-
term multilineage reconstitution. In a second experiment,
17 wk after the injection of 30 LT-HSC that had been in-
cubated alone for 1 h, followed by incubation with SDF-1 
for 2 h, four out of seven mice were reconstituted with do-
nor cells, and three out of seven mice displayed long-term
multilineage reconstitution.
Table I. PCR Primers Used for Analysis of Chemokine Receptor mRNA Expression by HSC. DHFR, Dihydrofolate Reductase
Receptor Sequence Size
bp
XCR1 Sense 5 -CAT CCC TGA TGC TGT CTT CCA C-3  346
Anti-sense 5 -AAT GAG AGA AGG CCA AAT GGC G-3 
CCR1 Sense 5 -AGC CTA CCC CAC AAC TAC AGA A-3  546
Anti-sense 5 -CTT GTA GGG GAA ATG AGG GCT A-3 
CCR2 Sense 5 -GGT CAT GAT CCC TAT GTG G-3  253
Anti-sense 5 -CTG GGC ACC TGA TTT AAA GG-3 
CCR3 Sense 5 -TGG GCA ACA TGA TGG TTG TG-3  383
Anti-sense 5 -GCT GTC TTG AGA CTC ATG GA-3 
CCR4 Sense 5 -CCA AAG ATG AAT GCC ACA GAG-3  1,090
Anti-sense 5 -CCT TAC AAA GCG TCA CGG AAG-3 
CCR5 Sense 5 -GCT GAA GAG CGT GAC TGA TA-3  362
Anti-sense 5 -GAG GAC TGC ATG TAT AAT GA-3 
CCR6 Sense 5 -GGG CAA CAT TAT GGT GGT GAT GAC-3  650
Anti-sense 5 -ACC GCA GTC ACG AGG AGG ACC ATG-3 
CCR7 Sense 5 -ACA GCG GCC TCC AGA AGA ACA GCG G-3  344
Anti-sense 5 -TGA CGT CAT AGG CAA TGT TGA GCT G-3 
CCR8 Sense 5 -CGA TGG AGC CCA ACG TCA CG-3  424
Anti-sense 5 -GGC CGT CCT CAC CTT GAT GGC-3 
CCR9 Sense 5 -TGC TGA TCT GCT CTT TCT TG-3  477
Anti-sense 5 -GTG CTT GGA TGA CTT CTT GG-3 
CXCR2 Sense 5 -AAC AGT TAT GCT GTG GTT GTA-3  483
Anti-sense 5 -CAA ACG GGA TGT ATT GTT ACC-3 
CXCR3 Sense 5 -GAA CGT CAA GTG CTA GAT GCC TCG-3  631
Anti-sense 5 -GTA CAC GCA GAG CAG TGC G-3 
CXCR4 Sense 5 -GGC TGT AGA GCG AGT GTT GC-3  390
Anti-sense 5 -GTA GAG GTT GAC AGT GTA GAT-3 
CXCR5 Sense 5 -AAA CGA AGC GGA AAC TAG AGC C-3  402
Anti-sense 5 -GCC CAG CTT GGT CAG AAG CC-3 
CX3CR1 Sense 5 -GCC ATC GTC CTG GCC GCC AAC TCC-3  564
Anti-sense 5 -GAC CGC ACA GGA CGG CCA GGC AC-3 
DHFR Sense 5 -CCA CAA CCT CTT CAG TGG AAG GTA AAC AGA-3  159
Anti-sense 5 -TTG GCA AGA AAA TGA GCT CCT CGT GG-3 1149 Wright et al.
HSC Express mRNA for CCR3, CCR9, and CXCR4.
In parallel with the chemotaxis studies, we tested for ex-
pression of mRNAs encoding the chemokine receptors for
the chemokines addressed in this study, plus the chemokine
receptors XCR1 (lymphotactin [XCL1] receptor) and
CX3CR1 (fractalkine [CX3CL1] receptor). Chemokine
receptor expression was determined by RT-PCR from
samples representing 1,000 double-sorted HSC (this sorted
population contained both LT-HSC and ST-HSC) or
1,000 unfractionated whole bone marrow (WBM) cells as a
positive control. CXCR4 (SDF-1  receptor) mRNA was
easily detected in HSC at the 1,000 cell level. CCR3 (eo-
taxin and RANTES receptor) and CCR9 (TECK recep-
tor) messages were also detected (Fig. 3 A and Table IV),
and XCR1, CXCR2 (KC/IL-8 receptor), and CXCR5
(BLC receptor) mRNA were observed inconsistently.
Other chemokine receptors were not detectably expressed
in HSC, although they were clearly present in RNA iso-
lated from an equivalent number of WBM cells. Because it
is conceivable that the in vivo migratory behavior of LT-
HSC and ST-HSC differ, and that these differences could
be reflected in chemokine receptor expression, we further
examined CCR3, CCR9, and CXCR4 mRNA expression
by LT-HSC and ST-HSC individually. CCR3, CCR9, and
CXCR4 mRNA expression was detected in both LT-HSC
and ST-HSC (Fig. 3 B).
SDF-1  Responses of HSC from BM of Untreated Mice Are
Indistinguishable from Responses of HSC Derived from BM,
Blood, and Spleens of Cy/G-CSF–treated Mice. It has been
suggested that decreased responsiveness to SDF-1   may
play a role in the mobilization of human hematopoietic
progenitors from BM to blood (16). We tested this hypoth-
esis in the mouse by examining the chemotaxis of HSC de-
rived from BM, blood, and spleens of Cy/G-CSF–treated
Figure 1. LT-HSC and ST-HSC migrate in response to SDF-1 , but are refractory to other chemokines and to G-CSF. (A) Flow cytometry contour
plots showing partial enrichment of BM cells for HSC by lineage depletion (upper two panels), and gating of lineage  LT-HSC (boxed cells, lower left)
and lineagelo ST-HSC (boxed cells, lower right). See the Materials and Methods section for details. (B and C) Lineage-depleted BM cells were prepared
and added to inserts placed in wells containing medium alone, the listed chemokines, or G-CSF (see the Materials and Methods section for concentra-
tions). Responding cells were harvested, stained for HSC markers, and analyzed for the presence and number of (B) LT-HSC and (C) ST-HSC by flow
cytometry. The data presented are the means  SD of two to nine independent experiments and represent the percentage of input HSC that migrated to
each chemokine or to G-CSF. Numbers in parentheses indicate the number of experiments performed for each agent. CC and CXC refer to the receptor
families to which the listed chemokines belong. Compared with basal migration, only migration to SDF-1  was statistically significant (P   0.05).1150 Hematopoietic Stem Cells Selectively Migrate to SDF-1 
animals. When compared with HSC from the BM of un-
treated mice, PB-, BM-, and spleen-derived HSC from
Cy/G-CSF–treated animals showed indistinguishable re-
sponsiveness to SDF-1  (Fig. 4). In addition, both MPB
and mobilized spleen HSC expressed easily detectable
CXCR4 mRNA by RT-PCR (unpublished data).
Discussion
HSC migrate in several circumstances: (a) HSC are
thought to migrate through the blood to seed new sites of
hematopoiesis during embryonic and fetal development
(for review see reference 2); (b) HSC migrate continuously
between BM and blood in normal adult animals (3–5); (c)
HSC migrate in large numbers from BM to blood after the
treatment of animals with cytotoxic agents such as Cy and/
or cytokines such as G-CSF (23, 27); and (d) injected HSC
migrate efficiently to hematopoietic tissues after transplan-
tation in experimental animals, or after clinical transplanta-
tion in humans (28). Because HSC have now been shown
to also have the capacity to give rise to nonhematopoietic
tissues such as liver, migrating HSC may represent a source
of pluripotent cells that are constantly available for the re-
pair of damaged organs. Here, we report the first compre-
hensive study to address the chemotactic responsiveness of
HSC to chemokines.
Table II. Chemokines Used and Their Known Receptors. 
Standardized Chemokine Names Are Given in Parentheses
Receptors Chemokines
CCR1 RANTES (CCL5)
CCR2 JE (CCL2)
CCR3 Eotaxin (CCL11), RANTES (CCL5)
CCR4 TARC (CCL17)
CCR5 RANTES (CCL5), MIP-1  (CCL4)
CCR6 MIP-3  (CCL20)
CCR7 MIP-3  (CCL19)
CCR8 I-309 (CCL1)
CCR9 TECK (CCL25)
CXCR2 KC (CXCL1–3), IL-8 (CXCL8)
CXCR3 MIG (CXCL9)
CXCR4 SDF-1  (CXCL12)
CXCR5 BLC (CXCL13)
Figure 2. (A) HSC migration to SDF-1  is chemotactic, not chemo-
kinetic. Lineage-depleted BM cells were prepared and added to inserts
placed in wells. SDF-1  was present in either the bottom well, the top
well (the insert), or in both the top and bottom wells. Responding cells
were harvested, stained for HSC markers, and analyzed for LT-HSC and
ST-HSC by flow cytometry. The data represent the percentage of input
HSC that migrated to the bottom well. HSC migrated only in the pres-
ence of a gradient of increasing SDF-1  concentration. (B) HSC
chemotaxis to SDF-1  does not require cells other than HSC. 15,000
Thy-1.1loSca-1 Lin /loc-Kit  cells (this population contains both LT-HSC
and ST-HSC) from BM of untreated mice were sorted directly into in-
serts placed in wells containing SDF-1 . 30,000 of the same cells were
sorted into inserts placed in wells only containing medium to establish
basal migration. Responding cells were collected and analyzed by flow
cytometry. The data represent the percentage of input HSC that migrated
to the bottom well.
Table III. Exposure to SDF-1  Does Not Alter the Long-Term 
Engraftment Potential of LT-HSC Injected at Near Limit
Dilution Doses
Hours of exposure Reconstitution pattern
n In culture SDF-1  LTMR
Percent
LTMR B, T B, M B None
A
60 0 4 6 700 0 2
63 0 4 6 720 0 0
5 3 0.5 3 60 2 0 0 0
63 1 4 6 710 0 1
83 2 4 5 031 0 0
B
83 0 4 5 010 1 2
73 2 3 4 310 0 3
(A) Experiment 1. The long term competitive repopulation assay was
performed (Materials and Methods) with 40 double-sorted LT-HSC
injected per recipient mouse. LT-HSC were incubated in vitro without
(in culture) or with SDF-1  as indicated. Peripheral blood of recipient
mice was analyzed by flow cytometry for the presence of donor-derived
B, T, and myeloid cells 31 wk after transplant. Data shown are the
number or percentage of mice with the indicated reconstitution
patterns. An RxC  test of independence using the G test with the
Williams’ correction revealed that there are no significant differences
among the groups (0.9   P   0.975). (B) Experiment 2. Same as
experiment 1, except that 30 LT-HSC per recipient were injected and
the mice were analyzed 17 wk after transplant. An RxC test of
independence using the G test with the Williams’ correction revealed
that there are no significant differences between the groups (0.5   P  
0.9). Abbreviations: B, B cells, LTMR, long-term multilineage
reconstitution; M, myeloid cells; T, T cells.1151 Wright et al.
The role of chemokines in hematopoiesis includes guid-
ing progenitor cells to microanatomical sites in BM or thy-
mus for proper maturation (29). However, the roles of
chemokines in the migrations of HSC during embryonic
and fetal development, the maintenance of adult HSC
niches, and the physiological flux of HSC between BM and
blood in adults are unclear. Here we showed that in nor-
mal adult animals, BM-derived LT-HSC and ST-HSC
displayed a sharply restricted responsiveness pattern to che-
mokines; they only migrated appreciably in response to
SDF-1 . Consistent with this, HSC express mRNA for
CXCR4, the only known receptor for SDF-1 . The SDF-
1 –CXCR4 interaction is important in hematopoietic de-
velopment, and may have a role in engraftment of BM by
HSC. Among other defects, mice lacking either SDF-1  or
CXCR4 lack lymphomyeloid hematopoiesis in fetal BM
(30, 31). The antibody blockade of CXCR4 prevented en-
graftment of adult SCID mouse BM by CD34 -enriched
human cord blood cells (32).
Our data suggest that HSC, in contrast to other leuko-
cyte subsets, only respond to SDF-1 . However, the possi-
bility exists that HSC may respond to other chemokines or
chemoattractants that we have not tested in this study. Al-
though HSC express mRNA for CCR3 and CCR9 (lack
of antibodies against murine chemokine receptors precluded
determination of whether CCR3 or CCR9 proteins were
present on the cell surface of HSC), they did not migrate in
response to eotaxin or RANTES, ligands for CCR3, or in
Figure 3. LT-HSC and ST-HSC contain mRNA for CCR3, CCR9, and CXCR4. (A) RT-PCR analysis of mRNA for chemokine receptors of
combined LT-HSC and ST-HSC (Thy-1.1loSca-1 Lin /loc-Kit  cells). RT-PCR was performed on RNA isolated from the equivalent of 1,000 double-
sorted HSC, or from 1,000 unfractionated WBM cells. Representative data are shown (see Table IV for data summary). (B) Additional RT-PCR was
performed on mRNA isolated from the equivalent of 1,000 LT-HSC or 1,000 ST-HSC for the receptors found to be positive in the first screen. Both
LT-HSC and ST-HSC contained mRNA for CXCR4, CCR3, and CCR9. See the Materials and Methods section for RT-PCR protocol. DHFR, di-
hydrofolate reductase; WBM, whole bone marrow.
Table IV. Summary of RT-PCR Analysis of Chemokine 
Receptor mRNA Expression by HSC
Receptor Expressiona
XCR1   (1/3)
CCR1   (0/2)
CCR2   (0/4)
CCR3   (4/6)
CCR4   (0/2)
CCR5   (0/2)
CCR6   (0/2)
CCR7   (0/2)
CCR8   (0/2)
CCR9   (2/2)
CXCR2   (2/5)
CXCR3   (0/2)
CXCR4   (6/6)
CXCR5   (1/5)
CX3CR1   (0/3)
aNumbers in parentheses indicate the fraction of independent experi-
ments in which a PCR product was detectable.
Figure 4. The magnitude of the chemotactic response to SDF-1  by
HSC from BM of untreated mice is indistinguishable from the magnitude
of the chemotactic responses of HSC derived from BM, blood, or spleens
of Cy/G-CSF–treated mice. Lineage-depleted BM cells from untreated
animals, or BM, blood, or spleen cells from day 4 Cy/G-CSF–treated an-
imals were prepared and added to inserts placed in wells containing me-
dium alone or SDF-1 . Responding cells were harvested, stained for
HSC markers, and analyzed for the presence and number of LT-HSC and
ST-HSC by flow cytometry. The data presented are the means  SD of
four to nine independent experiments and represent the percentage of in-
put HSC that migrated. Numbers in parentheses indicate the number of
experiments performed. Shaded bar, LT-HSC; filled bar, ST-HSC.1152 Hematopoietic Stem Cells Selectively Migrate to SDF-1 
response to TECK, the ligand for CCR9. These data indi-
cate that receptor mRNA expression alone does not ade-
quately predict chemotactic responsiveness, as has been ob-
served in other studies (24, 33, 34). Knockout mice that do
not express functional CCR3 have been prepared and no
hematopoietic defects have been observed (Gerard, C., per-
sonal communication). Similarly, preliminary analyses of
CCR9 knockout mice do not reveal notable defects in the
development of most lymphoid compartments (Wurbel,
M.A., and Malissen, B., personal communication [35]).
Lack of migration by HSC to eotaxin, RANTES, and
TECK is also consistent with the absence of essential roles
for CCR3 and CCR9 in hematopoiesis.
Current models of leukocyte trafficking hold that che-
motactic responsiveness plays a critical role in the homing
of cells to particular microenvironments and in position-
ing cells within these microenvironments (36). Most
leukocyte subsets express multiple chemokine and chemoat-
tractant receptors, and migrate in response to several che-
mokines (37, 38). The possession of multiple chemokine
and chemoattractant receptors has been shown to allow
cells to maneuver in a stepwise fashion through spatial ar-
rays of chemokine and chemoattractant gradients (39).
This raises the question of the significance of the ex-
tremely selective responsiveness pattern to chemokines
exhibited by HSC.
BM has the challenging task of promoting the growth of
several cell lineages. The presumption that various lineages
have unique requirements for maturation has led to the
notion that BM is partitioned functionally into specialized
microenvironments, or “niches.” Although HSC niches
have not been characterized, evidence of their existence
comes from the observation that cloned stromal lines are
heterogeneous in their ability to maintain hematopoiesis in
vitro (40–43). A second observation supporting the niche
hypothesis is that transplanted HSC, when injected intra-
venously as discrete boluses, do not engraft BM of synge-
neic recipient animals unless the dose of HSC is extremely
large (44–48), or the recipient’s BM is injured by radia-
tion/cytotoxic drugs.
Given the unique requirement of HSC niches in sup-
porting both the maintenance of multipotency and differ-
entiation, it is tempting to speculate that the restricted che-
motactic responsiveness of HSC we observed might be
important in localizing HSC within their niches, at least
when they are actively participating in hematopoiesis. Pos-
session by HSC of multiple functional chemokine receptors
in a complex environment such as BM would be undesir-
able as it could lead to the inappropriate migration of HSC
out of the HSC niche. Ma et al. (49) recently proposed that
CXCR4 is required for the retention of B lineage and
granulocytic precursors in the fetal liver and BM. The pos-
sibility that CXCR4 might similarly promote the retention
of HSC in their BM niches remains to be fully tested, but is
supported by the observation that the administration to
mice of an SDF analogue that downmodulates CXCR4 re-
sulted in a greater than 30-fold increase in the number of
circulating Thy-1.1loLin Sca-1 c-Kit  cells (50).
In addition to promoting the maintenance of HSC in
specific microanatomical sites within BM, CXCR4 might
allow efficient homing back to BM by those HSC that are
released into the bloodstream. Using a cross-circulation
model, we have found that HSC continuously flux be-
tween BM and blood under physiological conditions. HSC
released from the BM into the circulation recolonize BM
in other locations (5). Therefore, the circulating pool of
HSC must have a mechanism for the efficient rehoming to
BM. The SDF-1 –CXCR4 interaction appears to play a
key role in the homing of transplanted human hematopoi-
etic progenitors to BM of NOD/SCID mice (32), and
SDF-1  promotes integrin-mediated arrest on vascular en-
dothelium of circulating CD34  cells (19). The SDF-1 –
CXCR4 interaction may have a similar role in the rehom-
ing to BM of murine HSC released physiologically into the
circulation or injected intravenously for transplantation.
Aiuti et al. (16) raised the possibility of a direct role for
SDF-1  in hematopoietic progenitor mobilization. In a
study of human BM and MPB CD34  cells, fewer MPB
CD34  cells responded to SDF-1  than CD34  cells iso-
lated from BM, and it was suggested that the reduction in
SDF-1  responsiveness might be part of the mechanism of
progenitor mobilization. But only a fraction of CD34  cells
are HSC (17, 18). We found that mouse HSC from MPB,
or from BM or spleens of Cy/G-CSF–treated animals,
were equally responsive to SDF-1  as HSC from BM of
untreated control animals. These data do not support a role
for changes in SDF-1  responsiveness in cytokine-induced
HSC mobilization. The disparity between the results of the
current study and those of Aiuti et al. (16) might be due to
the differences between progenitors and HSC, or it may
reflect species- or mobilization protocol–specific effects. In
preliminary experiments, the migration of mobilized
HSC to the following chemokine panel was also tested:
JE, eotaxin, thymus- and activation-regulated chemokine,
RANTES, MIP-1 , MIP-3 , MIP-3 , I-309, KC, IL-8,
MIG, and SDF-1 . Similar to untreated BM, mobilized
HSC migrated only to SDF-1  and did not respond to the
other chemokines or to G-CSF (unpublished data).
In conclusion, we report that HSC migrate to SDF-1 
but not to chemokines signaling through other known
chemokine receptors. To our knowledge, this is the first
report of a leukocyte subset that responds to a single che-
mokine, which makes HSC highly specialized in this re-
gard. It remains to be determined whether SDF-1 –
CXCR4 interactions play a role in HSC localization
within BM, or in the rehoming to BM by HSC that are re-
leased physiologically into the circulation. SDF-1  respon-
siveness is preserved in HSC isolated from BM, blood, and
spleens of Cy/G-CSF–mobilized mice.
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